 |
Previous Article | Next Article 
The Journal of Neuroscience, January 15, 1998, 18(2):648-657
Critical Elements Determining Diversity in Agonist Binding and
Desensitization of Neuronal Nicotinic Acetylcholine Receptors
Pierre-Jean
Corringer1,
Sonia
Bertrand2,
Sébastien
Bohler1,
Stuart J.
Edelstein3,
Jean-Pierre
Changeux1, and
Daniel
Bertrand2
1 Neurobiologie Moléculaire, Unité de
Recherche Associée au Centre National de la Recherche
Scientifique D1284, Institut Pasteur, 75724 Paris Cedex 15, France,
2 Département de Physiologie, Centre Médical
Universitaire (Faculté de Médecine), 1211 Geneva 4, Switzerland, and 3 Département de Biochimie,
Université de Genève, CH-1211 Geneva, Switzerland
To identify the molecular determinants underlying the
pharmacological diversity of neuronal nicotinic acetylcholine
receptors, we compared the 7 homo-oligomeric and 4 2
hetero-oligomeric receptors. Sets of residues from the regions
initially identified within the agonist binding site of the 4
subunit were introduced into the 7 agonist binding site, carried by
the homo-oligomeric 7-V201-5HT3 chimera. Introduction
of the 4 residues 183-191 into 7 subunit sequence (chimera
C2) selectively increased the apparent affinities for
equilibrium binding and for ion channel activation by acetylcholine,
resulting in a receptor that no longer displays differences in the
responses to acetylcholine and nicotine. Introduction of the 4
residues 151-155 (chimera B) produced a ~100-fold increase in the
apparent affinity for both acetylcholine and nicotine in
equilibrium binding measurements. In both cases electrophysiological
recordings revealed a much smaller increase (three- to sevenfold) in
the apparent affinity for activation, but the concentrations required
to desensitize the mutant chimeras parallel the shifts in apparent
binding affinity. The data were fitted by a two-state concerted model,
and an alteration of the conformational isomerization constant leading
to the desensitized state accounts for the chimera B phenotype, whereas
alteration of the ligand binding site accounts for the chimera
C2 phenotype. Point mutation analysis revealed that several
residues in both fragments contribute to the phenotypes, with a
critical effect of the G152K and T183N mutations. Transfer of 4
amino acids 151-155 and 183-191 into the 7-V201-5HT3
chimera thus confers physiological and pharmacological properties
typical of the 4 2 receptor.
Key words:
nicotinic receptor; neuronal; acetylcholine; desensitization; pharmacology; chimera
Copyright © 1998 Society for Neuroscience 0270-6474/98/182648-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Physiol Rev,
January 1, 2009;
89(1):
73 - 120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sun, X.-Q. Hu, M. B. Emerit, J. C. Schoenebeck, C. E. Kimmel, R. W. Peoples, A. Miko, and L. Zhang
Modulation of 5-HT3 receptor desensitization by the light chain of microtubule-associated protein 1B expressed in HEK 293 cells
J. Physiol.,
February 1, 2008;
586(3):
751 - 762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rayes, G. Spitzmaul, S. M. Sine, and C. Bouzat
Single-Channel Kinetic Analysis of Chimeric {alpha}7-5HT3A Receptors
Mol. Pharmacol.,
November 1, 2005;
68(5):
1475 - 1483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Law, R. H. Henchman, and J. A. McCammon
Chemical Theory and Computation Special Feature: A gating mechanism proposed from a simulation of a human {alpha}7 nicotinic acetylcholine receptor
PNAS,
May 10, 2005;
102(19):
6813 - 6818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rayes, M. J. De Rosa, M. Bartos, and C. Bouzat
Molecular Basis of the Differential Sensitivity of Nematode and Mammalian Muscle to the Anthelmintic Agent Levamisole
J. Biol. Chem.,
August 27, 2004;
279(35):
36372 - 36381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sallette, S. Bohler, P. Benoit, M. Soudant, S. Pons, N. Le Novere, J.-P. Changeux, and P. J. Corringer
An Extracellular Protein Microdomain Controls Up-regulation of Neuronal Nicotinic Acetylcholine Receptors by Nicotine
J. Biol. Chem.,
April 30, 2004;
279(18):
18767 - 18775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhao, Y.-P. Kuo, A. A. George, J.-H. Peng, M. S. Purandare, K. M. Schroeder, R. J. Lukas, and J. Wu
Functional Properties of Homomeric, Human {alpha}7-Nicotinic Acetylcholine Receptors Heterologously Expressed in the SH-EP1 Human Epithelial Cell Line
J. Pharmacol. Exp. Ther.,
June 1, 2003;
305(3):
1132 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. He, H. Zemkova, and S. S. Stojilkovic
Dependence of Purinergic P2X Receptor Activity on Ectodomain Structure
J. Biol. Chem.,
March 14, 2003;
278(12):
10182 - 10188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. He, T.-a. Koshimizu, M. Tomic', and S. S. Stojilkovic
Purinergic P2X2 Receptor Desensitization Depends on Coupling between Ectodomain and C-Terminal Domain
Mol. Pharmacol.,
November 1, 2002;
62(5):
1187 - 1197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dobelis, M. J. Marks, P. Whiteaker, S. A. Balogh, A. C. Collins, and J. A. Stitzel
A Polymorphism in the Mouse Neuronal alpha 4 Nicotinic Receptor Subunit Results in An Alteration in Receptor Function
Mol. Pharmacol.,
August 1, 2002;
62(2):
334 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Newell and S. M. J. Dunn
Functional Consequences of the Loss of High Affinity Agonist Binding to gamma -Aminobutyric Acid Type A Receptors. IMPLICATIONS FOR RECEPTOR DESENSITIZATION
J. Biol. Chem.,
June 7, 2002;
277(24):
21423 - 21430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fruchart-Gaillard, B. Gilquin, S. Antil-Delbeke, N. Le Novere, T. Tamiya, P.-J. Corringer, J.-P. Changeux, A. Menez, and D. Servent
Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor
PNAS,
February 20, 2002;
(2002)
42699899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Sgard, E. Charpantier, S. Bertrand, N. Walker, D. Caput, D. Graham, D. Bertrand, and F. Besnard
A Novel Human Nicotinic Receptor Subunit, alpha 10, That Confers Functionality to the alpha 9-Subunit
Mol. Pharmacol.,
January 1, 2002;
61(1):
150 - 159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Buisson and D. Bertrand
Chronic Exposure to Nicotine Upregulates the Human {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Function
J. Neurosci.,
March 15, 2001;
21(6):
1819 - 1829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Dineley and J. W. Patrick
Amino Acid Determinants of alpha 7 Nicotinic Acetylcholine Receptor Surface Expression
J. Biol. Chem.,
April 28, 2000;
275(18):
13974 - 13985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Levandoski, Y. Lin, L. Moise, J. T. McLaughlin, E. Cooper, and E. Hawrot
Chimeric Analysis of a Neuronal Nicotinic Acetylcholine Receptor Reveals Amino Acids Conferring Sensitivity to alpha -Bungarotoxin
J. Biol. Chem.,
September 10, 1999;
274(37):
26113 - 26119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Hope, D. Belelli, I. D. Mair, J. J. Lambert, and J. A. Peters
Molecular Determinants of (+)-Tubocurarine Binding at Recombinant 5-Hydroxytryptamine3A Receptor Subunits
Mol. Pharmacol.,
June 1, 1999;
55(6):
1037 - 1043.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. J. Marks, P. Whiteaker, J. Calcaterra, J. A. Stitzel, A. E. Bullock, S. R. Grady, M. R. Picciotto, J.-P. Changeux, and A. C. Collins
Two Pharmacologically Distinct Components of Nicotinic Receptor-Mediated Rubidium Efflux in Mouse Brain Require the beta 2 Subunit
J. Pharmacol. Exp. Ther.,
May 1, 1999;
289(2):
1090 - 1103.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. P. ROBERTSON, H. E. BJORN, and R. J. MARTIN
Resistance to levamisole resolved at the single-channel level
FASEB J,
April 1, 1999;
13(6):
749 - 760.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. G. Wilson and A. Karlin
Inaugural Article: Acetylcholine receptor channel structure in the resting, open, and desensitized states probed with the substituted-cysteine-accessibility method
PNAS,
January 30, 2001;
98(3):
1241 - 1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fruchart-Gaillard, B. Gilquin, S. Antil-Delbeke, N. Le Novere, T. Tamiya, P.-J. Corringer, J.-P. Changeux, A. Menez, and D. Servent
Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor
PNAS,
March 5, 2002;
99(5):
3216 - 3221.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|